{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:31:26Z","timestamp":1770960686213,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030019"],"award-info":[{"award-number":["82030019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite the high prevalence of metabolic dysfunction-associated steatohepatitis (MASH), the number of effective therapeutic targets is limited due to a vague understanding of its intricate pathogenesis. In this study, we reported that the expression of nuclear factor erythroid-derived 2-related factor 1 (NRF1), an endoplasmic reticulum (ER) membrane-bound transcription factor that governs the expression of proteasome subunit genes, was significantly reduced in liver tissues from MAFLD patients and from mice fed a high-fat diet (HFD) for 20 weeks. Liver-specific overexpression of NRF1 in mice markedly ameliorated HFD-driven hepatic steatosis, liver injury and inflammation. Elevated NRF1 expression restored the function of the proteasome, facilitating the degradation of unfolded and nonfunctioning proteins, thereby mitigating ER stress and reducing oxidative stress. Moreover, docosahexaenoic acid (DHA) was found to increase NRF1 expression, contributing to the amelioration of MASH. Mechanistically, DHA inhibited the ubiquitination of NRF1 via the cytoplasmic E3 ligases FBW7 and HRD1 at the ER membrane, thereby preventing its degradation. Liver-specific knockdown of NRF1 abrogated the protective effect of DHA on HFD-driven MASH in mice. Together, our findings underscore the pivotal role of NRF1 in the DHA-mediated amelioration of MASH and suggest that NRF1 is a potential therapeutic target for MASH management.<\/jats:p>","DOI":"10.1038\/s41419-025-08139-1","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:25:26Z","timestamp":1768573526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NRF1 is upregulated by docosahexaenoic acid to ameliorate MASH through the inhibition of ER stress"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-0470","authenticated-orcid":false,"given":"Mengchi","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4842-3646","authenticated-orcid":false,"given":"Chaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-1253","authenticated-orcid":false,"given":"Chengfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"8139_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Allen AM, Dubourg J, Noureddin M, Alkhouri N. Challenges and opportunities in NASH drug development. Nat Med. 2023;29:562\u201373.","journal-title":"Nat Med"},{"key":"8139_CR2","doi-asserted-by":"crossref","unstructured":"Ledford H. First US drug approved for a liver disease surging around the world. Nature https:\/\/www.nature.com\/articles\/d41586-024-00747-9 (2024).","DOI":"10.1038\/d41586-024-00747-9"},{"key":"8139_CR3","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei S, Wang L, Evans PC, Xu S. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today. 2024;29:103910.","journal-title":"Drug Discov Today"},{"key":"8139_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. Jama. 2020;323:1175\u201383.","journal-title":"Jama"},{"key":"8139_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/14728222.2022.2132145","volume":"26","author":"TL Laursen","year":"2022","unstructured":"Laursen TL, Mellemkj\u00e6r A, M\u00f8ller HJ, Gr\u00f8nb\u00e6k H, Kazankov K. Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease. Expert Opin Ther Targets. 2022;26:697\u2013705.","journal-title":"Expert Opin Ther Targets"},{"key":"8139_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41580-018-0040-z","volume":"19","author":"A Rousseau","year":"2018","unstructured":"Rousseau A, Bertolotti A. Regulation of proteasome assembly and activity in health and disease. Nat Rev Mol Cell Biol. 2018;19:697\u2013712.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8139_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818\u201322.","journal-title":"Science"},{"key":"8139_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev-cellbio-031320-101827","volume":"36","author":"MA Roberts","year":"2020","unstructured":"Roberts MA, Olzmann JA. Protein quality control and lipid droplet metabolism. Annu Rev Cell Dev Biol. 2020;36:115\u201339.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8139_CR9","unstructured":"National Institute of Diabetes Digestive Kidney Diseases. LiverTox: Clinical and Research Information on Drug-induced Liver Injury (2012)."},{"key":"8139_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4110\/in.2012.12.3.126","volume":"12","author":"Y Kim","year":"2012","unstructured":"Kim Y, Kim KY, Lee SH, Chung YY, Yahng S-A, Lee S-E, et al. A case of drug-induced hepatitis due to bortezomib in multiple myeloma. Immune Netw. 2012;12:126\u20138.","journal-title":"Immune Netw"},{"key":"8139_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molcel.2010.02.029","volume":"38","author":"SK Radhakrishnan","year":"2010","unstructured":"Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, Deshaies RJ. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell. 2010;38:17\u201328.","journal-title":"Mol Cell"},{"key":"8139_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molcel.2010.09.012","volume":"40","author":"J Steffen","year":"2010","unstructured":"Steffen J, Seeger M, Koch A, Kr\u00fcger E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell. 2010;40:147\u201358.","journal-title":"Mol Cell"},{"key":"8139_CR13","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2017.10.003","volume":"171","author":"SB Widenmaier","year":"2017","unstructured":"Widenmaier SB, Snyder NA, Nguyen TB, Arduini A, Lee GY, Arruda AP, et al. NRF1 is an ER membrane sensor that is central to cholesterol homeostasis. Cell. 2017;171:1094\u20131109.e15.","journal-title":"Cell"},{"key":"8139_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.133","volume":"49","author":"SK Shin","year":"2017","unstructured":"Shin SK, Kim JH, Lee JH, Son YH, Lee MW, Kim HJ, et al. Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro. Exp Mol Med. 2017;49:e287.","journal-title":"Exp Mol Med"},{"key":"8139_CR15","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3390\/nu12092597","volume":"12","author":"JH Lee","year":"2020","unstructured":"Lee JH, Jeon JH, Lee MJ. Docosahexaenoic acid, a potential treatment for sarcopenia, modulates the ubiquitin-proteasome and the autophagy-lysosome systems. Nutrients. 2020;12:2597.","journal-title":"Nutrients"},{"key":"8139_CR16","doi-asserted-by":"publisher","first-page":"18938","DOI":"10.1021\/jacs.2c06827","volume":"144","author":"B Gagestein","year":"2022","unstructured":"Gagestein B, von Hegedus JH, Kwekkeboom JC, Heijink M, Blomberg N, van der Wel T, et al. Comparative photoaffinity profiling of omega-3 signaling lipid probes reveals prostaglandin reductase 1 as a metabolic hub in human macrophages. J Am Chem Soc. 2022;144:18938\u201347.","journal-title":"J Am Chem Soc"},{"key":"8139_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.32647","volume":"77","author":"C L\u00f3pez-Vicario","year":"2023","unstructured":"L\u00f3pez-Vicario C, Sebasti\u00e1n D, Casulleras M, Duran-G\u00fcell M, Flores-Costa R, Aguilar F, et al. Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease. Hepatology. 2023;77:1303\u201318.","journal-title":"Hepatology"},{"key":"8139_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143861","volume":"131","author":"TJ Grevengoed","year":"2021","unstructured":"Grevengoed TJ, Trammell SA, Svenningsen JS, Makarov MV, Nielsen TS, Jacobsen JCB, et al. An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. J Clin Invest. 2021;131:e143861.","journal-title":"J Clin Invest"},{"key":"8139_CR19","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.jhepr.2021.100346","volume":"3","author":"L Parlati","year":"2021","unstructured":"Parlati L, Regnier M, Guillou H, Postic C. New targets for NAFLD. JHEP Rep. 2021;3:100346.","journal-title":"JHEP Rep."},{"key":"8139_CR20","doi-asserted-by":"publisher","first-page":"39282","DOI":"10.1074\/jbc.M111.253807","volume":"286","author":"M Biswas","year":"2011","unstructured":"Biswas M, Phan D, Watanabe M, Chan JY. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis. J Biol Chem. 2011;286:39282\u20139.","journal-title":"J Biol Chem"},{"key":"8139_CR21","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1128\/MCB.05663-11","volume":"31","author":"Y Tsuchiya","year":"2011","unstructured":"Tsuchiya Y, Morita T, Kim M, Iemura S-i, Natsume T, Yamamoto M, et al. Dual regulation of the transcriptional activity of Nrf1 by \u03b2-TrCP-and Hrd1-dependent degradation mechanisms. Mol Cell Biol. 2011;31:4500\u201312.","journal-title":"Mol Cell Biol"},{"key":"8139_CR22","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1136\/gutjnl-2021-325013","volume":"71","author":"MU Latif","year":"2022","unstructured":"Latif MU, Schmidt GE, Mercan S, Rahman R, Gibhardt CS, Stejerean-Todoran I, et al. NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression. Gut. 2022;71:2561\u201373.","journal-title":"Gut"},{"key":"8139_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh0831","volume":"9","author":"E Boslem","year":"2023","unstructured":"Boslem E, Reibe S, Carlessi R, Smeuninx B, Tegegne S, Egan CL, et al. Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC. Sci Adv. 2023;9:eadh0831.","journal-title":"Sci Adv"},{"key":"8139_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2021.01.042","volume":"75","author":"C Liu","year":"2021","unstructured":"Liu C, Zhou B, Meng M, Zhao W, Wang D, Yuan Y, et al. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. J Hepatol. 2021;75:150\u201362.","journal-title":"J Hepatol"},{"key":"8139_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen C, Chen J, Sang T, Peng H, Lin X, et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biol. 2022;52:102322.","journal-title":"Redox Biol"},{"key":"8139_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102105","volume":"46","author":"T Mahata","year":"2021","unstructured":"Mahata T, Sengar AS, Basak M, Das K, Pramanick A, Verma SK, et al. Hepatic regulator of G protein signaling 6 (RGS6) drives non-alcoholic fatty liver disease by promoting oxidative stress and ATM-dependent cell death. Redox Biol. 2021;46:102105.","journal-title":"Redox Biol"},{"key":"8139_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162533","volume":"134","author":"S Greatorex","year":"2023","unstructured":"Greatorex S, Kaur S, Xirouchaki CE, Goh PK, Wiede F, Genders AJ, et al. Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity. J Clin Invest. 2023;134:e162533.","journal-title":"J Clin Invest"},{"key":"8139_CR28","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.plipres.2022.101198","volume":"89","author":"C Celik","year":"2023","unstructured":"Celik C, Lee SYT, Yap WS, Thibault G. Endoplasmic reticulum stress and lipids in health and diseases. Prog Lipid Res. 2023;89:101198.","journal-title":"Prog Lipid Res"},{"key":"8139_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/hep.32562","volume":"77","author":"A Ajoolabady","year":"2023","unstructured":"Ajoolabady A, Kaplowitz N, Lebeaupin C, Kroemer G, Kaufman RJ, Malhi H, et al. Endoplasmic reticulum stress in liver diseases. Hepatology. 2023;77:619\u201339.","journal-title":"Hepatology"},{"key":"8139_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/antiox12050981","volume":"12","author":"G Ong","year":"2023","unstructured":"Ong G, Logue SE. Unfolding the interactions between endoplasmic reticulum stress and oxidative stress. Antioxidants. 2023;12:981.","journal-title":"Antioxidants"},{"key":"8139_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/nu11040872","volume":"11","author":"J Yang","year":"2019","unstructured":"Yang J, Fernandez-Galilea M, Martinez-Fernandez L, Gonzalez-Muniesa P, Perez-Chavez A, Martinez JA, et al. Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation. Nutrients. 2019;11:872.","journal-title":"Nutrients"},{"key":"8139_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"S Talukdar","year":"2010","unstructured":"Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687\u201398.","journal-title":"Cell"},{"key":"8139_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nm1168","volume":"11","author":"A Hirasawa","year":"2005","unstructured":"Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11:90\u201394.","journal-title":"Nat Med"},{"key":"8139_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6220","volume":"380","author":"C Mao","year":"2023","unstructured":"Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, et al. Unsaturated bond recognition leads to biased signal in a fatty acid receptor. Science. 2023;380:eadd6220.","journal-title":"Science"},{"key":"8139_CR35","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.bpj.2021.04.009","volume":"120","author":"ML Jacobs","year":"2021","unstructured":"Jacobs ML, Faizi HA, Peruzzi JA, Vlahovska PM, Kamat NP. EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol. Biophys J. 2021;120:2317\u201329.","journal-title":"Biophys J"},{"key":"8139_CR36","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/1873-3468.12825","volume":"591","author":"D Hishikawa","year":"2017","unstructured":"Hishikawa D, Valentine WJ, Iizuka-Hishikawa Y, Shindou H, Shimizu T. Metabolism and functions of docosahexaenoic acid-containing membrane glycerophospholipids. FEBS Lett. 2017;591:2730\u201344.","journal-title":"FEBS Lett"},{"key":"8139_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000448262","volume":"69","author":"PC Calder","year":"2016","unstructured":"Calder PC. Docosahexaenoic acid. Ann Nutr Metab. 2016;69:7\u201321.","journal-title":"Ann Nutr Metab"},{"key":"8139_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fmolb.2019.00030","volume":"6","author":"R Motosugi","year":"2019","unstructured":"Motosugi R, Murata S. Dynamic regulation of proteasome expression. Front Mol Biosci. 2019;6:30.","journal-title":"Front Mol Biosci"},{"key":"8139_CR39","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/cancers12051065","volume":"12","author":"D Fassmannova","year":"2020","unstructured":"Fassmannova D, Sedlak F, Sedlacek J, Spicka I, Grantz Saskova K. Nelfinavir inhibits the TCF11\/Nrf1-mediated proteasome recovery pathway in multiple myeloma. Cancers. 2020;12:1065.","journal-title":"Cancers"},{"key":"8139_CR40","doi-asserted-by":"publisher","first-page":"48021","DOI":"10.1074\/jbc.M308439200","volume":"278","author":"L Leung","year":"2003","unstructured":"Leung L, Kwong M, Hou S, Lee C, Chan JY. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem. 2003;278:48021\u20139.","journal-title":"J Biol Chem"},{"key":"8139_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112399","volume":"42","author":"MG Akl","year":"2023","unstructured":"Akl MG, Li L, Baccetto R, Phanse S, Zhang Q, Trites MJ, et al. Complementary gene regulation by NRF1 and NRF2 protects against hepatic cholesterol overload. Cell Rep. 2023;42:112399.","journal-title":"Cell Rep."},{"key":"8139_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107212","volume":"145","author":"R Deng","year":"2024","unstructured":"Deng R, Zhu Y, Liu K, Zhang Q, Hu S, Wang M, et al. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway. Bioorg Chem. 2024;145:107212.","journal-title":"Bioorg Chem"},{"key":"8139_CR43","doi-asserted-by":"crossref","unstructured":"Akl MG, Li L, Widenmaier SB Protective effects of hepatocyte stress defenders, Nrf1 and Nrf2, against MASLD progression. Int J Mol Sci 25, 8046 (2024).","DOI":"10.3390\/ijms25158046"},{"key":"8139_CR44","doi-asserted-by":"publisher","first-page":"33554","DOI":"10.1074\/jbc.M804597200","volume":"283","author":"M Ohtsuji","year":"2008","unstructured":"Ohtsuji M, Katsuoka F, Kobayashi A, Aburatani H, Hayes JD, Yamamoto M. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem. 2008;283:33554\u201362.","journal-title":"J Biol Chem"},{"key":"8139_CR45","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1042\/BJ20151182","volume":"473","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xiang Y. Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity. Biochem J. 2016;473:961\u20131000.","journal-title":"Biochem J"},{"key":"8139_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1042\/BJ20060725","volume":"399","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Crouch DH, Yamamoto M, Hayes JD. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum. Biochem J. 2006;399:373\u201385.","journal-title":"Biochem J"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08139-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08139-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:03:00Z","timestamp":1768579380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08139-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8139"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08139-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}